Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 703 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
RR
H.A. CUMBER & COMPANY, INC. for BAUSCH & LOMB
2nd Quarter (Apr 1 - June 30) 2026 · Florida
Medical/Disease Research/Clinical Labs, Pharmacy
View →
Q2
TROUTMAN STRATEGIES for MURAL HEALTH
2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate · $50,000.00 income
Health Issues, Taxation/Internal Revenue Code, Medical/Disease Research/Clinical Labs
View →
Q2
CAPITOL COUNSEL LLC for TEMPUS LABS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Illinois · House · Senate · $80,000.00 income
Science/Technology, Medicare/Medicaid, Health Issues, Medical/Disease Research/Clinical Labs
View →
Q2
CAPITOL COUNSEL LLC for MADRIGAL PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate · $60,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
BALLARD PARTNERS for REVELLE AESTHETICS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · $300,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q2
CAPITOL COUNSEL LLC for BRISTOL-MYERS SQUIBB
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $60,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
CAPITOL COUNSEL LLC for BOEHRINGER INGELHEIM ANIMAL HEALTH US
2nd Quarter (Apr 1 - June 30) 2026 · Georgia · Senate · $50,000.00 income
Animals, Medical/Disease Research/Clinical Labs
View →
Q2
FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) for PHARMATROPHIX, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · Senate · $10,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs
View →
Q2
BARNES & THORNBURG, LLP for SINAI HEALTH SYSTEM
2nd Quarter (Apr 1 - June 30) 2026 · Illinois · House · Senate · $20,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
CAPITOL COUNSEL LLC for ALNYLAM PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $30,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q2
CHECKMATE GOVERNMENT RELATIONS for NEPHRON NITRILE D/B/A AMERICAN ARMOR GLOVES
2nd Quarter (Apr 1 - June 30) 2026 · South Carolina · House · Senate · $50,000.00 income
Defense, Medical/Disease Research/Clinical Labs
View →
Q2
UNIVERSITY OF KENTUCKY for UNIVERSITY OF KENTUCKY
2nd Quarter (Apr 1 - June 30) 2026 · Kentucky · House · Senate
Agriculture, Medical/Disease Research/Clinical Labs, Science/Technology, Defense
View →
Q2
WINNING STRATEGIES WASHINGTON for SPINAL STABILIZATION TECHNOLOGIES, LTD
2nd Quarter (Apr 1 - June 30) 2026 · Colorado · House · Senate · $40,000.00 income
Budget/Appropriations, Defense, Health Issues, Medical/Disease Research/Clinical Labs
View →
2A
WINNING STRATEGIES WASHINGTON for I AM ALS
2nd Quarter (Apr 1 - June 30) 2026 · Illinois · House · Senate · $20,000.00 income
Medical/Disease Research/Clinical Labs, Budget/Appropriations, Health Issues
View →
Q2
WINNING STRATEGIES WASHINGTON for I AM ALS
2nd Quarter (Apr 1 - June 30) 2026 · Illinois · House · Senate · $10,000.00 income
Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs
View →
RR
FORBES-TATE for I AM ALS
3rd Quarter (July 1 - Sep 30) 2026 · District of Columbia
Health Issues, Medical/Disease Research/Clinical Labs, Veterans, Budget/Appropriations
View →
Q2
ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) for ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Government Issues, Medical/Disease Research/Clinical Labs, Budget/Appropriations
View →
Q2
WINNING STRATEGIES WASHINGTON for DIABETES PATIENT ADVOCACY COALITION
2nd Quarter (Apr 1 - June 30) 2026 · Kentucky · House · Senate · $20,000.00 income
Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q2
MUSCULAR DYSTROPHY ASSOCIATION, INC. for MUSCULAR DYSTROPHY ASSOCIATION, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Illinois · House · Senate
Transportation, Education, Health Issues, Aviation/Airlines/Airports
View →
Q2
FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) for INTUITIVE SURGICAL, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · Senate · $40,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs
View →
Q2
IPOLICY SOLUTIONS for ASSOCIATION FOR FRONTOTEMPORAL DEGENERATION
2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate · $45,000.00 income
Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs
View →
Q2
OAK RIDGE ASSOCIATED UNIVERSITIES, INC. for OAK RIDGE ASSOCIATED UNIVERSITIES, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Tennessee · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Energy/Nuclear, Science/Technology
View →
Q2
WISE CAPITAL STRATEGY, LLC for AMITY HOLDINGS LLC DBA PIP DIABETES CARE
2nd Quarter (Apr 1 - June 30) 2026 · Tennessee · House · Senate
Medical/Disease Research/Clinical Labs
View →
Q2
IPOLICY SOLUTIONS for ASSOCIATION FOR MOLECULAR PATHOLOGY
2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate · $70,500.00 income
Medical/Disease Research/Clinical Labs, Copyright/Patent/Trademark, Medicare/Medicaid
View →
RR
DEAF DIPLOMACY GROUP / DEAF HEALTH COALITION for DEAF DIPLOMACY GROUP / DEAF HEALTH COALITION
3rd Quarter (July 1 - Sep 30) 2026 · Maryland
Budget/Appropriations, Civil Rights/Civil Liberties, Education, Government Issues
View →
Previous Page 10 of 29 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem